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L-plastin is a leukocyte-speciﬁc protein that cross-links actin ﬁlaments into tight bundles, increasing the stability of actin-based
structures such as podosomes and lamellipodia. While ﬁrst identiﬁed as an abundant cytoplasmic protein in hematopoietically
derived cells over 25 years ago, the requirement for L-plastin in multiple functions critical for immunity, such as antigen receptor
signaling, adhesion, and motility, has only recently become clear. L-plastin has been identiﬁed as an important component in
cellular processes critical for neutrophil, macrophage, osteoclast, eosinophil, and T- and B-lymphocyte biology. Following a brief
description of the structure and function of L-plastin, the regulation of immune cell functions by L-plastin will be reviewed in
detail.
1.Introduction
The actin cytoskeleton enables numerous cellular processes
required for the mammalian immune response. Actin is rap-
idlypolymerizedinresponsetoT-cellreceptorsignaling,and
F-actin provides stability for the contact site between anti-
gen-presenting cells and T cells, termed the immunological
synapse [1–4]. Actin cytoskeletal elements are also recruited
duringchemotacticandadhesiveresponses,processescritical
to normal leukocyte traﬃcking and motility [5–10]. Phago-
cytosis and intracellular killing of pathogens also relies upon
actin cytoskeletal elements [11, 12]. While many actin-bind-
ing proteins regulate the recruitment and stabilization of the
actin cytoskeleton, recent studies have implicated the actin-
bundling protein L-plastin (LPL) as a critical regulator of
actin dynamics in cells of both the adaptive and innate im-
mune systems.
2. LPLExpression,Structure,andFunction
Plastins, or ﬁmbrins, are actin-bundling proteins critical to
a c t i nr e g u l a t i o ni ne u k a r y o t e s .H u m a nﬁ m b r i nc a nc o m p l e -
ment yeast SAC6 in endocytosis, suggesting a high degree
of conservation [13]. Three isoforms, L-, I-, and T-plastin,
comprise the vertebrate plastins. LPL was initially found in
transformed human ﬁbroblasts, though it was later recog-
nized that normal expression of LPL is restricted to cells
of the hematopoietic lineage [14–18]. LPL, also called lym-
phocyte cytosolic protein 1 (LCP1), has been described as
one of the 15 most abundant proteins in human monocytes
and T cells [14]. The human isoform I-plastin is expressed
in mammalian small intestine, colon, and kidney [19, 20].
T-plastin has the broadest tissue distribution and has been
found in most cells from solid tissues with replicative po-
tential, such as ﬁbroblasts and epithelial cells [16, 18]. All
three plastins contain two N-terminal EF-hands, homolo-
gous to calmodulin-calcium-binding domains, followed by
two actin-binding domains (ABDs). Unlike I- and T-plast-
in, LPL additionally contains N-terminal sites of serine pho-
phorylation (Figure 1).
Plastins bind F-actin through ABDs that each consists
of two calponin-homology domains, placing plastins in the
α-actinin family. Other α-actinin family members include
α-actinin, ﬁlamin, spectrin, dystrophin, and actin-binding
protein 120 [16, 21]. Plastins are unique among these family
members in that they contain two tandem ABDs on the same
polypeptide. These tandem ABDs are thought to fold into
a compact, horseshoe-like structure that can simultaneously2 International Journal of Cell Biology
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Figure 1:SchematicofthestructureofLPL.TheN-terminal“head-
piece” contains at least one serine phosphorylation site (arrow; ser-
ine residue 5) and EF hand loops (labeled “EF”) that are thought
to participate in the calcium regulation of LPL. The C-terminal
portion contains two tandem ABDs, each of which consists of two
calponin-homology (CH) domains, which are numbered.
bind two actin ﬁlaments, thus cross-linking the ﬁlaments
into tight bundles [22]. An atomic model of actin ﬁlament
bundling by T-plastin was generated through electron mi-
croscopy of 2D actin arrays polymerized in the presence or
absence of T-plastin on lipid bilayers [23, 24]. Bundled actin
arrays were unipolar, with about 120 ˚ A between ﬁlaments,
and bundling may generate hexagonal lattices [24]. Incor-
poration of T-plastin into actin bundles occurred primarily
during actin polymerization; cross-linking of ﬁlaments was
irregular when preformed actin ﬁlaments were incubated
with T-plastin. T-plastin-bundled ﬁlaments could bend at
sites of T-plastin cross-links, likely through changes in the
twist of the bound actin ﬁlament [24].
While LPL is thought to bundle actin in a manner similar
to the homologous T-plastin (Figure 2), direct conﬁrmation
throughexperimentaldemonstrationhasbeenelusive.Imag-
ing of actin ﬁlaments has been limited by the intrinsic disor-
der of F-actin, as ﬁlaments contain variable twist and tilt of
actin subunits. This limitation was overcome by using high-
resolution cryoelectron microscopy to image the binding of
LPL to F-actin [25] .T h e s ei m a g e so fL P L - d e c o r a t e dF - a c t i n
revealed that binding of the ABD2 of LPL reduced the
variability in actin twist and resulted in a more “closed” con-
formation of the nucleotide-binding cleft in actin subunit.
As an “open” conformation of the nucleotide-binding cleft
is correlated with depolymerization and actin ﬁlament
instability, “closure” of the cleft by LPL oﬀers a molecular
understanding of prior results indicating that LPL binding
stabilized the polymerized actin ﬁlament [26]. The interac-
tion of the ABD1 of LPL with F-actin was too variable to be
described using the same technique of cryo-electron micro-
scopy, although a prior report indicated that the binding
of ABD1 of LPL likely resembles the binding of α-actinin
[25, 26]. It is unclear whether the ABD1 or the ABD2 of LPL
ﬁrst binds to F-actin [25, 26]. While the exact molecular
mechanism of LPL bundling to F-actin remains to be exper-
imentally delineated, the binding sites of ABD1 and ABD2
have been described [26], and it seems likely that LPL func-
tions similarly to T-plastin in cross-linking ﬁlaments [24].
No molecular function beyond actin bundling has been
described for LPL. However, as outlined below, peptides
derived from the N-terminus of LPL lacking ABD domains
can promote changes in cell functions, such as integrin avid-
ity and cell adhesion. These results suggest that LPL may play
a role as an adaptor or a scaﬀolding protein in signaling
in addition to its actin-bundling activity, roles that require
further experimental elucidation. Also, as will be discussed
below, the details of mechanisms by which actin bundling
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Figure 2: LPL folds into a compact structure that bundles actin
ﬁlaments. Numbers indicate each CH domain. Based on available
experimental data, it has been proposed that ABD2 binds to a
polymerizing actin ﬁlament such that the nucleotide-binding cleft
adoptsamore“closed”position,thusstabilizingtheﬁlament.Bind-
ing of ABD1 to an adjacent ﬁlament cross-links F-actin into tight
bundles.
may promote or restrain immune cell functions have not yet
been fully described.
3. Regulation of LPL
Regulation of the bundling of activity of LPL has been
demonstrated to occur through both calcium binding and
serine phosphorylation. LPL is phosphorylated in multiple
cell types primarily at serine residue 5 following a variety of
stimuli, including IL-1, IL-2, lipopolysaccharide, fMet-Leu-
Phe, FcγR ligation, and PMA [27–31]. To study the eﬀect of
serine phosphorylation on the binding of LPL to F-actin, the
serine5residuewasmutatedtoeitheranonphosphorylatable
alanine residue (S5A mutant) or to a glutamic acid residue
(S5E mutant), that mimicked constitutive phosphorylation
[32].Wild-typeandmutantLPLwereexpressedinVerocells,
which do not express endogenous LPL. Phosphorylation of
LPL was found to enhance the targeting of LPL to F-actin
rich structuresandregions ofrapid actinassembly,including
membrane ruﬄes and microspikes. Phosphorylation of LPL
increased its binding to F-actin, as the S5E mutant LPL had a
much higher actin-bundling activity than did wild-type LPL
[32]. Analysis of ﬂuorescence recovery after photobleaching
(FRAP) of GFP-tagged wild-type and S5A mutant LPL in
Vero cells revealed that phosphorylation of LPL increased its
localizationtofocaladhesionsitesandreduceditslateralmo-
bility, again suggesting an increase in binding of phosphory-
lated LPL to F-actin [33]. Phosphorylated LPL also reduced
the turnover of actin ﬁlaments in focal adhesions to a greater
extent than non-phosphorylatable LPL, although nonphos-
phorylatable LPL also stabilized F-actin [33]. Thus, when ec-
topically expressed in Vero cells, serine phosphorylation may
directly regulate the bundling function of LPL.International Journal of Cell Biology 3
LPL may diﬀer from I- and T-plastin in that calcium
binding negatively regulates LPL-bundling activity [34]. In
an in vitro assay, it was determined that calcium concentra-
tions of greater than 10−6M reduced the binding of LPL to
F-actin, while LPL binding to F-actin was intact at concen-
trations of less than 10−7Mc a l c i u m[ 34]. Calcium binding
may induce conformational changes in LPL, thus altering its
actin-binding ability [22]. Phosphoinositides have also been
reported to reduce the interaction between LPL and actin
ﬁlaments [26].
LPL may also be regulated through direct binding by
other proteins. For instance, binding of the protein-ionized
calcium binding adaptor molecule 1 (Iba1) to LPL in macro-
phages enhanced the bundling capability of LPL, indepen-
dently of the intrinsic bundling capability of Iba1 [35]. Iba1
is a macrophage-speciﬁc, actin-bundling protein that local-
izes to membrane ruﬄes and participates in phagocytosis
[35]. Binding of LPL to cortactin has been described in Vero
cells in which LPL has been ectopically expressed [33]. The
macrophage-speciﬁc protein grancalcin may bind LPL di-
rectly [36],andvimentinandLPLarecomplexedinadherent
macrophages [37]. Finally, calmodulin binding may aﬀect
the function of LPL in stimulated T cells [38]. Whether the
binding of cortactin, grancalcin, or calmodulin modulates
the bundling capacity of LPL has not been determined.
Despite much work on the various mechanisms by which
LPLmayberegulated,anintegrateddescriptionofhowthese
mechanismsinteractduringaspeciﬁccellprocessinaspecif-
ic cell type, such as macrophage adhesion, has not emerged.
Such an integrated description is challenging, because the
regulation of LPL likely varies from cell type to cell type and
from stimulus to stimulus. In fact, diﬀerent receptors for the
same stimulus can regulate LPL via diﬀerent signaling path-
ways [39]. However, given the abundance of LPL in hemato-
poietic cells, and its recruitment into a wide variety of proc-
esses critical to immune function, a more thorough explora-
tion of the regulation of LPL is warranted.
4. LPLRegulates IntegrinFunction
in Neutrophils
The most extensive characterization of a role for LPL in
hematopoieticcellshasbeenperformedinneutrophils.Criti-
cal to the immediate, innate host defense, neutrophils rely on
complex interactions between Fc receptors, chemoattractant
receptors,andintegrinstoguideneutrophilmaturation,traf-
ﬁcking, and degranulation [40]. Regulation of integrin avid-
ity through inside-out signaling and integrin-mediated out-
side-in signaling is crucial to eﬀective neutrophil function
[41–43]. The predominance of evidence indicates that LPL
participates in both inside-out and outside-in signaling [29,
44], although LPL may also function downstream of FcγRi n
some systems.
LPL was initially recognized in neutrophils as a target
of phosphorylation following stimulation with IL-8 or the
chemoattractant peptide fMet-Leu-Phe [45, 46]. LPL was
independently found to be a downstream mediator of FcγR
signaling when LPL was identiﬁed as a target of bromo-
phenacyl bromide (BPB) [47]. BPB inhibited FcγR-mediated
calcium ﬂux and diminished neutrophil degranulation, ad-
herence,andphagocytosis.BPB-mediatedinhibitionofFcγR
signaling correlated with the binding of BPB to LPL. Intrigu-
ingly, BPB did not prevent the FcγR-stimulation binding of
LPL to F-actin, suggesting that LPL may have a function be-
yond that of actin bundling in FcγR signaling in neutrophils
[47]. Further work revealed that FcγRII activation through
bead- or plate-bound immune complexes induced phos-
phorylation of the N-terminal headpiece of LPL, while stim-
ulation with soluble immune complexes did not [48]. Im-
mune complexes consisted of bovine serum albumin (BSA)
bound with varying concentrations of anti-BSA antibodies.
Phosphorylation of LPL under conditions in which cells had
to reorganize to engage with a ﬁxed ligand but not in re-
sponse to simple receptor triggering by a soluble ligand sug-
gested that LPL may be involved in the cellular shape change
inducedbybindingtoﬁxedligands[48].Furthermore,plate-
bound immune complexes also induced the movement of
LPL to podosomes. However, LPL phosphorylation occurred
independently of the translocation to podosomes, calcium
ﬂux, and actin polymerization. Blockade of the integrin
αMβ2 (also called CR3, Mac-1, and CD11b/CD18) did not
aﬀect LPL phosphorylation, but did reduce the translocation
of LPL to the podosomes on immune complex coated sur-
faces [48]. Thus, it was not clear in early work whether the
phosphorylation of LPL promoted association with F-actin
in neutrophils stimulated through plate-bound FcγR, and
the precise regulation and function of LPL in neutrophils
adhering to surface-bound ligands remain to be fully de-
scribed.
A mechanistic link between phosphorylation of LPL and
activation of the integrin αMβ2 in neutrophils was revealed
inhumanneutrophilstreatedwithacell-permeablesynthetic
peptide derived from the N-terminal headpiece of LPL [29].
Signals that generate changes in integrin adhesion also trig-
gered LPL phosphorylation; LPL phosphorylation in neutro-
phils could be induced by both PI3K-dependent FcγRs i g -
naling and by PI3K-independent f-Met-Leu-Phe and PMA
stimulation. The serine 5 residue in the N-terminus of LPL
was identiﬁed as the primary target of phosphorylation in
these signaling pathways. A synthetic peptide derived from
residues 2–19 of the N-terminus of LPL was fused at the car-
boxy terminus to the HIV tat protein, which enabled sponta-
neous translocation of the LPL peptide across the cell mem-
brane. Treatment of neutrophils with the wild-type sequence
of LPL was suﬃcient to induce adhesion of neutrophils to
surfaces coated with fetal calf serum, a process mediated
through the activation of the integrin αMβ2. Treatment with
a constitutively phosphorylated synthetic LPL peptide also
induced adhesion, while mutation of the serine residue at
position 5 to alanine to prevent phosphorylation abrogated
the induction of neutrophil adhesion. Induction of adhesion
bywild-typeLPLtat butnotbyconstitutivelyphosphorylated
LPLtat could be inhibited by blocking PI3K and PKC, indi-
cating that phosphorylation of LPL through these signaling
pathways was likely necessary for the ability of LPL to induce
activation of αMβ2 and thus neutrophil adhesion [29]. Ad-
ditionally, blockade of LPL phosphorylation by treatment
with the PKA-inhibitor H89 correlated with inhibition of4 International Journal of Cell Biology
adhesion to immune complex coated surfaces and likely in-
hibited activation of αMβ2[ 49].
Induction of integrin activation was conﬁrmed and ex-
tended through the examination of activation of αvβ3 in the
human erythroleukemic cell line K562, which enabled anal-
ysis of the function of LPL in a well-established system of
activable integrin adhesion [50]. Similar to the observation
that a synthetic LPL peptide could upregulate the adhesion
ofαMβ2inneutrophils[29],treatmentofK562cellsexpress-
ing αvβ3 with the LPLtat peptide promoted integrin acti-
vation and cellular adhesion to surfaces coated with the in-
tegrin ligand vitronectin [50]. LPLtat activation of αvβ3w a s
independentofthetyrosinephosphorylationofthecytoplas-
mic tail of the integrin β chain, indicating that LPL activates
integrins in a mechanism diﬀerent from that of PMA stim-
ulation. LPLtat treatment of cells triggered a conformation
change in the integrin, revealing ligand-induced binding
sites on the integrin that increased its avidity for its ligand.
Changes in integrin avidity required actin depolymerization
[50]. These results conﬁrmed that the action of LPL was not
restricted to one speciﬁc integrin, and further elucidated the
mechanism by which LPL can activate integrins in neutro-
phils and K562 cells. Whether LPL bound directly to inte-
grins αMβ2a n dαvβ3 was not examined in these studies.
However, LPL has recently been reported to exist in com-
plexes with either β1o rβ2 integrins in breast and prostate
cancercells,consistentwiththeproposalthatLPLcandirect-
ly regulate integrin activity [21].
5. Regulation of LPL Phosphorylation
in Neutrophils
Phosphorylation of LPL has also been linked to generation
of NADPH-oxidative burst in neutrophils following stimu-
lation with PMA. Both nonphosphorylated and hyperphos-
phorylation of LPL correlated with inhibition of PMA-
generated NADPH oxidative burst. Optimally phosphorylat-
ed LPL correlated with induction of NADPH oxidative burst
[51]. These results suggested turnover of LPL phosphory-
lation may be as critical as phosphorylation itself. Whether
or not that turnover of LPL phosphorylation functions in
the generation of the oxidative burst in response to other
extracellularsignalshasnotbeeninvestigatedinthismanner.
The kinases that phosphorylate LPL in neutrophils vary
with cell stimulus (Table 1). Immune complex binding trig-
gers phosphorylation of LPL at the serine 5 residue through
PKA [49]. However, the inhibitor of PKA, H89, did not
inhibit LPL phosphoryaltion in response to PMA or fMLP
stimulation [49]. Characterization of LPL phosphorylation
in response to fMLP revealed multiple signaling pathways
that converge at LPL phosphorylation. Inhibitors of PI3K,
PLD, and PKC could all reduce LPL phosphorylation in re-
sponse to fMLP stimulation, and the recruitment of the dif-
ferent kinases depended upon whether signaling occurred
through the high-aﬃnity or low-aﬃnity receptor of fMLP
[39]. LPL was independently found to be a substrate of phos-
phorylation following ligation of the low-aﬃnity recep-
tor for fMLP, formyl peptide receptor-like 1 (FPR-L1) [30].
Intriguingly, multiple species of LPL—a 67kDa, 65kDa,
62kDa, and 48kDa—were isolated from fMLP-stimulated
neutrophils. The signﬁcance of these diﬀerent molecular
weight forms of LPL is completely unknown [30].
Given the increase in integrin activation and adhesion
triggered by the LPLtat peptide, it was somewhat of a
surprisetoﬁndthatneutrophilsfromtheLPL−/− mousewere
notdefectiveinintegrin-mediatedadhesion,norwaschemo-
taxis of LPL−/− neutrophils diminished [44]. However,
LPL−/− neutrophils were defective in integrin signaling to
the kinase Syk. Deﬁcient activation of Syk following integrin
ligation led to a defective respiratory burst, resulting in an
inability to kill Staphylococcus aureus,a n dL P L −/− mice were
more susceptible to staphylococcal skin abscesses. Signal-
ing through both FcγR and PMA to the respiratory burst
in LPL−/− neutrophils was intact, indicating that integrin
signaling was speciﬁcally dependent upon LPL [44]. These
results, combined with those described above, suggest that
LPL may be suﬃcient to promote changes in integrin adhe-
sion, but is not always necessary. However, LPL is required
for some aspects of integrin outside-in signaling.
6. LPL Promotes the Stabilizationof
the T-Cell Immune Synapse
In addition to its role in neutrophil biology, LPL has also
been recognized as a substrate of phosphorylation during T-
cell receptor signaling to T-cell activation as early as 1994
[52]. Phosphorylation or redistribution of LPL has been
used as a marker of T-cell activation and/or costimulation
[53, 54]. However, a functional requirement for LPL during
T-cell activation has only recently been described [55, 56].
T-cell activation is dependent upon the creation of a
specialized contact site between the antigen-presenting cell
(APC) and the responding T-cell [57, 58]. Described as both
the supramolecular activation complex (SMAC) and the im-
munological synapse (IS), the creation of this contactsite has
beenextensively reviewed[2,3,59].Ar olef o rLPLinthef o r -
mation of the IS was suggested by the ﬁndings that LPL
accumulates at the synapse [55]. Co-stimulation through
CD2 or CD28 induced phosphorylation of LPL at serine 5
[55]. While accumulation of LPL at the IS was independent
of its phosphorylation status, overexpression of a mutant of
LPL that could not be phosphorylated reduced the export
of the T-cell activation markers CD25 and CD69 [55]. An
additional study from the same group further characterized
the role of LPL in the formation of the mature IS [38]. They
found that during SMAC formation, LPL primarily colocal-
ized with F-actin in the peripheral and/or distal SMAC. As in
the previous study, mutation of the serine phosphorylation
siteatresidue5hadnoimpactontheabilityofLPLtolocalize
to the IS. However, deletion of an ABD or deletion of the
calmodulin-binding domain did prevent LPL accumulation
at the synapse. Knockdown of LPL through siRNA trans-
fection resulted in diminished actin polymerization during
synapse formation, reduced recruitment of talin and LFA-1
tothesynapse,andanoverallreductioninthesizeofthesyn-
apse.DefectiveISmaintenancecorrelatedwithareductioninInternational Journal of Cell Biology 5
Table 1: The kinases that regulate phosphorylation of LPL in response to various cell stimuli are listed, along with the inhibitor used to test
the participation of each kinase. The kinases that phosphorylate LPL in other cell types, such as T cells and macrophages, have not yet been
deﬁned. References are numbered according to appearance in the text.
Cell Type Receptor Ligand Inhibitor Kinase inhibited Ref.
Neutrophils FcγRI C H89
Wortmannin
PKA
PI3K [49]
Neutrophils FPR (high aﬃnity) fMLP Ro-31-8220 PKC [39]
Neutrophils FPR-L1 (low aﬃnity) fMLP
LY294002
butanol
Ro-31-8220
PI3K
PLD
PKC
[39]
Eosinophils GMR GM-CSF siRNA PKCβII [60]
Abbreviations: FcγR: receptor for the Fc portion of immunoglobulin; IC: immune complexes; fMLP: N-formyl-L-methionyl-L-leucyl-L-phenylalanine; PKA:
protein kinase A; PI3K: phosphatidylinositol 3-kinase; PKC: protein kinase C; FPR: formyl peptide receptor; FPR-L1: formyl peptide receptor-like 1; PLD:
phospholipase D; GM-CSF: granulocyte macrophage colony stimulating factor; GMR: GM-CSF receptor.
theproliferationofperipheralbloodTcellsinwhichLPLhad
been knocked down [38]. Recently, phosphorylation of LPL
has been identiﬁed as a target of dexamethasone, oﬀering a
novel mechanism for the immunosuppressive eﬀects of this
commonly used steroid [61].
A requirement for LPL in the formation of the immune
synapse was independently conﬁrmed through the analysis
of murine T cells genetically deﬁcient for LPL [56]. LPL−/−
murine T cells were defective in proliferation and cytokine
production when stimulated with plate-bound anti-CD3 or
with peptide-pulsed APCs, but not with soluble anti-CD3.
Interestingly,proximalTCRsignalingevents,suchascalcium
ﬂux, tyrosine phosphorylation of the adaptor protein LAT,
a n dE R Ka c t i v a t i o na n dw e r ei n t a c ti ns t i m u l a t e dL P L −/−
T cells. However, spreading of LPL−/− T cells on anti-CD3
coated surfaces, formation of LPL−/− T-cell: APC conjugates,
and generation of the IS in LPL−/− T cells were impaired.
These data are all consistent with a model in which LPL
is required for later stages of IS formation, stabilization,
or maintenance, but is dispensable for early TCR signaling
events. A requirement for LPL in later stages of signaling
would also be consistent with its identiﬁed functions in sta-
bilizing F-actin structures. Defective formation or mainte-
nance of the IS likely contributed to the downstream defects
in proliferation and cytokine production of LPL−/− Tc e l l s
[56]. It is not yet clear whether the requirement for LPL in
stabilization of the IS depends upon its actin-bundling activ-
ity, eﬀects upon integrin binding or adhesion, binding to
calmodulin, or some combination of these potential eﬀector
functions. Furthermore, the kinases that phosphorylate LPL
and the potential regulation of LPL by calcium, as is suggest-
ed by the binding of calmodulin to LPL [38], have not yet
been fully elucidated in TCR-stimulated T cells. Further-
more, while B-cell activation also requires actin rearrange-
ment, a role for LPL in B-cell receptor signaling has not yet
been fully investigated [62].
7. LPL Is Requiredfor Normal
T-andB-CellMotility
Lymphocyte traﬃcking is dependent upon an array of inte-
grins and chemoattractant receptors that promote changes
in cell polarity, adhesion, and motility [8, 63–66]. LPL has
also been recognized as a critical regulator of T-cell motility,
as well as T-cell activation. Like its role in TCR signaling,
LPLappearstofunctionasadownstreameﬀectorofmotility,
rather than as a participant in proximal chemokine recep-
tor signaling. LPL was identiﬁed along with coronin 1A as
one of several actin-binding proteins that move into and
then out of chemokine-receptor-associated lipid rafts fol-
lowing chemokine signaling. Knockdown of LPL in Jurkat
T cells reduced motility towards CCL20 without inhibiting
chemokine-stimulatedcalciumﬂux[67].TcellsfromLPL−/−
mice were also found to have diminished chemoattractant-
mediated motility, as assessed by two-photon microscopy in
e x p l a n t e dl y m p hn o d e sa sw e l la si nt r a n s w e l la s s a y s[ 68].
The reduction in motility occurred in chemokine-stimulated
LPL−/− T cells despite normal activation of the small GTPase
Rac,induction ofaburstofactinpolymerization, andupreg-
ulation of cellular adhesiveness thought to be due to integrin
activation. Motility reduction correlated with diminished
polarizationofLPL−/− Tcells,whichfailedtogenerateclearly
delineated uropods and lamellipods seen in chemokine-
stimulated WT T cells. Phenotypically, the reduced motility
of LPL−/− T cells resulted in diminished thymic egress in
LPL−/− mice [68]. While inhibition of immune cell motility
by an inverse agonist of the cannabinoid CB2 receptor cor-
related with diminished phosphorylation of LPL [69], a
requirement for LPL phosphorylation during T-cell chemo-
taxis has not yet been formally demonstrated, and whether
calmodulin-binding regulates the function or localization of
LPL during chemotaxis has not been examined.
BcellsalsorequireLPLforchemotaxis-mediatedmotility
[70].LPL−/− micewerefoundtobedeﬁcientforaspecialized
population of B cells, called marginal zone B cells. Develop-
ment of MZ B cells is exquisitely sensitive to chemotactic and
adhesive signaling, and LPL−/− B cells were found to exhibit
reduced motility towards the chemoattractants CXCL12,
CXCL13, and sphingosine-1-phosphate. Interestingly, the
integrin-mediated increase in cellular motility required LPL,
whilethe chemokine-mediated increase in integrin adhesive-
ness did not. As seen before, some downstream elements
of chemoattractant receptor signaling did not require LPL,
as activation of ERK and p38 were intact in CXCL12-stim-
ulated LPL−/− B cells. However, total protein levels and6 International Journal of Cell Biology
phosphorylation of the integrin-associated kinase Pyk2 were
diminished in LPL−/− B cells, providing a possible molecular
explanation for the requirement for LPL in lymphocyte
motility [70].
8.LPLIs anEarlyParticipantin
Sealing Ring Formation of Osteoclasts
Osteoclasts are highly specialized, hematopoietically derived
cells that maintain bone mass and remodel bone structure
throughthetightlyregulatedprocessofboneresorption[71].
LPL has been localized to the podosomes of monocyte-de-
rived osteoclasts [72], and a role for LPL, along with the
actin-binding protein cortactin, has been demonstrated in
osteoclast sealing ring formation [73]. Osteoclasts undergo
dramatic, actin-based morphologic changes during bone
resorption. Osteoclasts initially generate actin aggregates,
which are thought to provide traction for membrane exten-
sions. These actin aggregates then mature and form a sealing
ring. The expression of LPL was found to decrease during
the maturation of the sealing ring, while the expression of
cortactin increases during the same time period. LPL was
found to localize with the actin aggregates during the early
process of bone resorption, but not with the mature sealing
ring.WhileanabsoluterequirementforLPLintheformation
of the sealing ring has not yet been formally demonstrated,
these results suggest that LPL plays a critical function during
osteoclast adhesion [73].
9.LPLLocalizes to the Podosomes of
Macrophages duringMigration
LPL was identiﬁed as one of the major constituents of cyto-
plasmic gels isolated from alveolar macrophages, along with
actin, ﬁlamin, and α-actinin [17]. LPL was estimated to
account for about 1.8% of total cytoplasmic protein in ma-
crophages,existinginanapproximate1:7-8molarratiowith
actin. The authors proposed that calcium regulation of LPL
may alter microﬁlament organization in macrophages, as the
presence of 20μM calcium reduced the aﬃnity of LPL for
actin by threefold. LPL was also identiﬁed as a heavily phos-
phorylatedproteininmacrophagesstimulatedwithLPS[74].
As seen in other cell types, the phosphorylation occurs at
serine residue 5 of the amino terminus, though the kinase
responsible for LPL phosphorylation in LPS-stimulated ma-
crophages remains undeﬁned [31, 74]. A small amount of
constitutivelyphosphorylatedLPLhasbeenreportedtoasso-
c i a t ew i t hp o d o s o m e si nm a c r o p h a g e s[ 75].
The abundance of LPL in macrophage cytoplasm has
enabled the imaging of macrophage movement through
ﬂuorescently tagged LPL [76]. Fluorescently tagged LPL has
alsobeenusedinconjunctionwithﬂuorescentlylabeledactin
to analyze podosome assembly and disassembly in macro-
phage lamellipodia during migration [77]. Podosomes are
similar to focal adhesions and serve as sites of actin assembly
and adhesion during forward movement and are enriched
for integrins, vinculin, and talin. Podosomes are relatively
short lived, assembling and disassembling in a few minutes.
Dynamic changes in F-actin and LPL were tightly associated
both geographically and temporally, suggesting close cou-
pling between the regulation of the two proteins [77]. As
LPL is incorporated during actin polymerization [24], this
close coupling in time and space is not surprising. While LPL
is certainly an abundant component of podosomes, a re-
quirement for actin bundling in normal podosome assembly
and function has not yet been reported.
LPL has also been reported to bind to macrophage-spe-
cific proteins that may be critical to macrophage function.
For instance, LPL was found to bind Iba1 in a two-hybrid
screen [35]. The expression of Iba1, an EF-hand protein, is
upregulated in activated microglia and has been reported to
be critical for macrophage membrane ruﬄing and phagocy-
tosis.Iba1andLPLco-localizetophagocyticcups.Bindingof
Iba1 to LPL enhanced LPL bundling activity, independent of
theintrinsicbundlingabilityofIba1[35].LPLwasalsofound
to be a possible binding partner of grancalcin, a member
of the penta-EF-hand family [78]. Grancalcin is expressed
primarily inphagocyticcells,suchasneutrophils andmacro-
phages [36]. Grancalcin colocalized with F-actin in mem-
brane spikes of stimulated macrophages [36]. Unlike LPL−/−
neutrophils,grancalcin-deﬁcientneutrophilswereabletokill
Staphylococcus aureus in vitro, and grancalcin was not re-
quired for other immune functions, such as macrophage re-
cruitment to sites of inﬂammation or resistance to fungal
infections [79]. The functional association between LPL and
grancalcin thus remains undeﬁned.
10.LPL MediatesGM-CSFSensitization
of Eosinophils
A function of LPL in receptor signaling events beyond its
capacity as an actin-bundling protein has been suggested by
a recent report that LPL may regulate GM-CSF-mediated
sensitization of eosinophils [60]. GM-CSF stimulation pro-
moted the phosphorylation of LPL and the association of
LPL with protein kinase CβII and two subunits of the GM-
CSF receptor. Treatment with GM-CSF resulted in increased
expression of the integrin αMβ2, increased sensitivity to
eotaxin in a chemotaxis assay, prolonged survival of eosin-
ophils, and primed eosinophils for degranulation. Inhibition
of PKCβII resulted in the reduction of LPL phosphorylation
and the loss of these GM-CSF-stimulated eﬀects. Most im-
portantly, internalization of a constitutively phosphorylated
LPL peptide (residues 2–19) by eosinophils resulted in in-
creased αMβ2 integrin expression and sensitization to chem-
otaxis, suggesting a mechanistic link between phosphoryla-
tion of LPL and GM-CSF-induced sensitization to chemo-
taxis [60]. The induction of increased αMβ2 integrin expres-
sion by the N-terminal portion of LPL, which does not
contain ABDs, suggests that LPL may have intrinsic signaling
capabilities that do not require actin-bundling functions.
11. LPL MayPromote the Invasive
Potentialof Transformed Cells
LPL is ectopically expressed in many tumor cells, and its
function in the potential promotion of invasive potentialInternational Journal of Cell Biology 7
of transformed cells has been extensively reviewed [80]. In
brief, a survey of 59 human tumor cell lines revealed ectopic
expression of LPL in 66% of epithelial-derived carcinomas
and 53% of mesenchymal tumors [18]. Expression of LPL
has been correlated with higher stages of colorectal cancer
[81], and ectopic expression of LPL in a colon cancer cell
line promoted proliferation and invasion [82]. While total
expression of LPL did not correlate with staging of breast
cancer [83], the phosphorylation of LPL enabled breast can-
cer cell line resistance to TNF-α [84]. The invasive potential
of human melanoma cells was enhanced by the phosphory-
lation of ectopically expressed LPL [85]. Blockade of LPL by
the overexpression of an alpaca-derived nanobody reduces
invasion of prostate carcinoma cells in a matrigel invasion
assay[86].Finally,anonphosphorylatablemutantofLPLwas
unable to promote collagen gel invasion of HEK293T cells
[32]. Combined, these results suggest that LPL may function
in the formation of actin-based structures that facilitate the
metastatic potential of transformed cells [80].
12.Toward anIntegratedModelofLPL
Despite 25 years of research, an integrated understanding of
the function of LPL in hematopoietic cells remains elusive.
A clear description of the role of LPL has been frustrated
by the inherent technical diﬃculties of analyzing the rapid,
transient, and subcellular events of receptor signaling, adhe-
sion, and motility that are dependent upon the highly dy-
namic actin cytoskeleton. Advances in imaging technology
will address these diﬃculties. Additionally, the requirement
for LPL may vary with cell type and cell stimulus, as LPL was
required for chemoattractant-mediated motility of lympho-
cytes [68, 70], but not migration of neutrophils [44]. It may
be that the diﬀerential requirement for LPL in lymphocytes
and neutrophils results from the utilization of diﬀerent
modes of motility [10, 87]. It is also possible that the differ-
ential requirement for LPL in distinct cell types results from
disparate expression patterns of LPL-binding proteins, such
as grancalcin [36]. Furthermore, it has not yet been estab-
lished whether LPL regulates receptor signaling, adhesion,
and motility solely through its actin-bundling function or if
LPL can also act as an adaptor protein in signaling cascades.
A function for LPL beyond actin-bundling has been
recently suggested by the observation that LPL binds directly
to the cytoplasmic portion of integrins β1a n dβ2 though
the ABDs [21]. This interaction between LPL and integrins
β1a n dβ2 may be regulated by μ-calpain cleavage [21]. LPL
was also identiﬁed in a screen for proteins upregulated in a
leukemic cell line that constitutively maintains integrins in
an activated state [88]. A critical role for LPL in integrin sig-
naling would reconcile a number of otherwise apparently
disparate observations. For instance, stabilization of the IS
in T cells, the adhesion-mediated triggering of the NADPH
oxidativeburstinneutrophils,andthestabilizationofF-actin
in the podosomes of macrophages are all integrin-mediated
events [38, 44, 56, 77]. The requirement for LPL in signal-
ing has often been revealed when suspension cells, such as
neutrophils or T cells, were stimulated with surface-bound,
but not soluble, ligand, consistent with the proposal that
LPL functions primarily in transmitting adhesion-generated
signals [48, 56]. The demonstration of defective polarization
of chemokine-stimulated LPL−/− T cells was performed on a
surface coated with integrin ligand [68]. Whether LPL regu-
lates “inside-out” integrin signaling may be cell type depen-
dent. LPL upregulated integrin avidity in neutrophils [29],
but upregulation of integrin avidity following chemokine
stimulation was not LPL-dependent in lymphocytes [68, 70].
Integrin outside-in signaling required LPL in both lympho-
cytes and neutrophils [44, 68, 70]. Whether LPL links inte-
grinsdirectlytotheactincytoskeletonorservesasanadaptor
protein in a larger molecular complex remains unclear.
Mutations in cytoskeletal proteins, such as Wiskott-
AldrichSyndromeprotein,coronin,DOCK8andRac2,result
inhumanimmunodeﬁciency[89–92].Whethermutationsin
or allelic forms of LPL contribute to human immunodeﬁ-
ciency is an open question. One of the ﬁrst reports of LPL
noted an alternatively expressed form in one of nine patients
examined [14]. It does not appear that this observation has
been clariﬁed in the intervening decades. Given the now ex-
tensive evidence that LPL plays critical functions in macro-
phage, neutrophil, eosinophil, and lymphocyte biology, fur-
therinvestigationofaroleforLPLininfectionandimmunity
is well warranted.
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